There’s an old you — wild or not. But there’s also a new you. Easy as A, B, C to leave Hep C behind. #NewYou

Congratulations to @aivl.bsky.social on a successful and inclusive Peer & Harm Reduction Summit in Boorloo (Perth). Fantastic to see the amazing work that peers and communities are achieving across the country. This work is essential to achieving and maintaining hepatitis elimination.

Something big is brewing at Hepatitis Australia.. 👀 Stay tuned!

Earlier this month, Hepatitis Australia hosted a World Hepatitis Day event at Parliament House, and it was great to see so many people in the room. Here’s a snapshot of the energy, contributions, and connections that made the event so special.

A partnership between Hepatitis ACT and Capital Chemist O'Connor is making hepatitis C treatment accessible by ensuring hep C medicine is always available for those who need it. On World Pharmacists Day, we extend our gratitude to pharmacists everywhere for the difference you make every day. 💚

The @un.org has released its final draft political declaration ahead of Thursday’s High-Level Meeting on Non-Communicable Diseases. For the first time, hepatitis testing, treatment and vaccination are included as cancer prevention measures. @worldhepalliance.bsky.social

Australia has the tools, treatments and partnerships needed to eliminate hepatitis B and C by 2030. Hepatitis Australia has launched a new report, 'Achieving 2030', which shows the progress achieved to-date, and the consequences of falling short of hepatitis B and hepatitis C elimination targets.

Today, Hepatitis Australia attended the Pharmacy Guild of Australia's Women's Health Event at Parliament House. We got to explore a life-sized consult room and learn more about the growing role pharmacists play in supporting women's health.

Hepatitis Australia hosted a HepLink planning and implementation workshop in Tartanya/Adelaide. It was fantastic to bring together our members from across the country to embed implementation of the updated HepLink model to ensure everyone in Australia has a pathway to viral hepatitis services.

Hepatitis Australia is looking for people to participate in a virtual focus testing activity, to help inform a hepatitis C campaign. For more information or to express your interest, please send us a DM or email us via [email protected] by (DATE).

Do you have questions about performance and image-enhancing drugs (PIEDs)? If so, The Juice has the answers! The Juice provides factual information about PIED injecting and promotes safe injection practices to protect your health. 💪Check it out at thejuice.org.au! @aivl.bsky.social

Last week Hepatitis Australia had the privilege of attending the VH2025 conference in Naarm, Melbourne. It was great to learn about the latest developments in the viral hepatitis space and to connect with members and industry stakeholders. Thank you to ASHM for putting together a great conference

Yesterday, Hepatitis Australia contributed to key conversations across the sector, with our team presenting on a range of topics. Thank you to everyone who joined the sessions and contributed to the dialogue. We’re looking forward to more important discussions and connections before it wraps up.

Yesterday marked day 1 of the #VH2025 conference! Hepatitis Australia was proud to be part of several key sessions focused on community-led action and hepatitis elimination, and connecting with community members and partners in the sector.

Yesterday, Hepatitis Australia hosted a scoping workshop with sector stakeholders to explore ways to collaborate and improve access to care and monitoring for people with hepatitis B. We look forward to continued collaboration in this important space. The workshop was hosted by Doherty Institute.

Hepatitis Australia's Senior Policy Analyst Ashma Shrestha attended the Healthcare in Secure Settings Conference. Her paper, developed with ASID and NACCHO, highlighted the urgent need to implement needle and syringe programs (NSPs) in prisons to support hepatitis C elimination in Australia.

For World Hepatitis Day, @hepatitiswa.bsky.social‬ launched an important new website, which will make a big difference for people living with hepatitis B in multicultural, remote, and regional areas in Western Australia. Check it out! 🌐 www.hepbwa.com.au 📍 Now available in the Mid-West region

It was a pleasure for Hepatitis Australia's CEO Lucy Clynes to join the Pharmacy Guild of Australia's President Trent Twomey to celebrate the lowering of the PBS medicine co-pay to $25. This will make medicines more affordable for those living with hepatitis B and hepatitis C in Australia.

On World Hepatitis Day, Hepatitis Australia's CEO Lucy Clynes and Lead Policy Analyst Ashma Shrestha were so pleased to meet with Dr Mike Freelander MP, Member for Macarthur, to discuss the ongoing challenges faced by people affected by hepatitis B and hepatitis C.

Yesterday @hepatitisact.bsky.social‬ hosted a WHD Breakfast to thank those who champion hepatitis awareness and health equity across the region. We heard from the ACT Minister for Health Rachel Stephen Smith & Lucy Clynes, CEO at Hepatitis Australia, about the ongoing commitment to elimination.

On 28 July, landmarks in Adelaide and Victor Harbor will glow green to mark #WorldHepatitisDay. Look out for it. @hepatitisaustralia.bsky.social @hepatitiswa.sbky.social

NEW STUDY | Menzies’ researchers have led the largest-ever study of people living with a unique strain of chronic hepatitis B (C4 hep B), uncovering significant impacts on liver health. Learn more about these findings and the work of the Hep B PAST Plus program: www.menzies.edu.au/page/News_an...

Hepatitis Australia's #WorldHepatitisDay Factsheet 2025 is available now! The latest stats and priorities towards Australia's hepatitis elimination objectives. #TakeActionAustralia for #WorldHepatitisDay Get the facts: www.worldhepatitisday.org.au/factsheet

Plenary sessions showcasing "Real People, Real Action, Real Results" announced for the 15th Australasian Viral Hepatitis Conference happening this 6-8 August in Naarm (Melbourne). Register for #VH2025: www.hepatitis.org.au/registration...

HEP B STORY | We’re proud to share the Hep B Story App is now available in 11 Aboriginal languages, with new additions: Wubuy and Murrinh Patha. Check out this hepatitis B health education resource: www.menzies.edu.au/page/Resourc... @hepbvoicesau.bsky.social @hepatitisaustralia.bsky.social

It was great to join the NSW Hepatology Nurses Meeting last night alongside Hepatitis NSW! We discussed some of the incredible work happening in partnership between community and nurses and to strengthen our work together as we progress towards Australia's 2030 elimination targets.

Congratulations to Hepatitis NSW on today’s successful Viral Elimination and Beyond Summit! Great to be bringing the conversation about eliminating viral hepatitis to NSW Parliament.

Hi, we're excited to be on BlueSky! 👋 We're the national peak body for community hepatitis orgs, advocating for people impacted by hepatitis B and C. Need support? HepLink Australia provides confidential and free hepatitis information and support services. Call 1800 437 222 or visit helplink.au.

In this conversation with Rich Condit, Thomas Tu (@thatliverguy.bsky.social) shares his journey with Hep B from diagnosis to dedicating his career to finding answers, and opens up about the science, the stigma, and his experience. 📺 Watch now: www.youtube.com/watch?v=5LM8...

Imagine curing #hepC in a single dose. Work's been done on this. If successful & cost-effective, healthcare providers can test, diagnose & treat hep C in a single encounter. hepatitissa.asn.au/communitynew... @worldhepalliance.bsky.social @hepatitisaustralia.bsky.social @hcvaction.bsky.social

Join Hepatitis Australia's Programs Director, Michelle Kudell, at ASHM's #CtheWholeStory Forum online on 29 May where she'll be presenting on HepLink Australia and the importance of co-design and community innovation. Register for free here! ashm.org.au/education/c-... #hepatitisC

Have questions about hepatitis? Ask @hepatitissa.asn.au! You can also call HepLink Australia at 1800 437 222 for confidential, free and localised viral hepatitis information and support services.